AZMIRO FDA approval date

The FDA approved AZMIRO on 2 Jun 2022.

FDA approval date
2 Jun 2022

Drug identity has not yet been verified against registry records

Also recorded as TESTOSTERONE CYPIONATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2022-06-02DayAZMIROFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA216318", "applicant_as_listed_by_fda": "AZURITY", "brand_names": ["AZMIRO"], "active_ingredients": ["TESTOSTERONE CYPIONATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20220602", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026